An etiological approach to psychosis: potential benefits for treatment, research and prevention.

Current treatment of psychosis focuses on antipsychotic medication, and rarely addresses the factors that have contributed to the onset and persistence of the disorder. We suggest that the most useful way of facilitating treatment, research and prevention is to identify the causal risk factors to which psychotic patients have been exposed. Operating on a background of genetic vulnerability, the main types of environmental risk factors for psychosis comprise impaired neurodevelopment, substance abuse, and social adversity. In most patients with psychosis, striatal dopamine dysfunction, often mediated by disrupted gamma-aminobutyric acid (GABA)ergic and glutamatergic signaling in the hippocampus, appears to be the final common pathway from those distal risk factors to positive symptoms. There are clinical and biological differences among individuals who develop psychosis following exposure to the different risk factors. For example, those with impaired neurodevelopment are more likely to show minor physical anomalies or soft neurological signs, cognitive deficits, and brain structural abnormalities. Individualized interventions need to be offered to those patients who have been exposed to particular risk factors. For example, in addition to antipsychotic medication, patients who continue to use cannabis should be offered cognitive behavioral/motivational therapy to decrease their substance consumption, while patients who were exposed to child abuse could be offered trauma-based therapy, and antidepressants as appropriate. Of course, many patients have been exposed to more than one type of risk factor. Such patients deserve therapeutic action directed to each of those risk pathways. In addition to promoting individualized treatment, attention to etiology could benefit research, allowing the study of psychological and biological characteristics of patients whose psychosis appears to have resulted predominantly from one particular risk factor, and could open the door to universal and selective preventive strategies to decrease psychosis incidence through reducing exposure to risk factors.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-10-01
DOI
https://doi.org/10.1002/wps.70079
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

An etiological approach to psychosis: potential benefits for treatment, research and prevention.

Dominic Oliver, Luis Alameda, Robin M. Murray, Aikaterini Dima
PubMed
Schizophrenia research and treatment
article

An etiological approach to psychosis: potential benefits for treatment, research and prevention.

Dominic Oliver, Luis Alameda, Robin M. Murray, Aikaterini Dima
article en

Abstract

Current treatment of psychosis focuses on antipsychotic medication, and rarely addresses the factors that have contributed to the onset and persistence of the disorder. We suggest that the most useful way of facilitating treatment, research and prevention is to identify the causal risk factors to which psychotic patients have been exposed. Operating on a background of genetic vulnerability, the main types of environmental risk factors for psychosis comprise impaired neurodevelopment, substance abuse, and social adversity. In most patients with psychosis, striatal dopamine dysfunction, often mediated by disrupted gamma-aminobutyric acid (GABA)ergic and glutamatergic signaling in the hippocampus, appears to be the final common pathway from those distal risk factors to positive symptoms. There are clinical and biological differences among individuals who develop psychosis following exposure to the different risk factors. For example, those with impaired neurodevelopment are more likely to show minor physical anomalies or soft neurological signs, cognitive deficits, and brain structural abnormalities. Individualized interventions need to be offered to those patients who have been exposed to particular risk factors. For example, in addition to antipsychotic medication, patients who continue to use cannabis should be offered cognitive behavioral/motivational therapy to decrease their substance consumption, while patients who were exposed to child abuse could be offered trauma-based therapy, and antidepressants as appropriate. Of course, many patients have been exposed to more than one type of risk factor. Such patients deserve therapeutic action directed to each of those risk pathways. In addition to promoting individualized treatment, attention to etiology could benefit research, allowing the study of psychological and biological characteristics of patients whose psychosis appears to have resulted predominantly from one particular risk factor, and could open the door to universal and selective preventive strategies to decrease psychosis incidence through reducing exposure to risk factors.

PubMedVol. 25(3)
Oxleas NHS Foundation Trust (GB), King's College London (GB), South London and Maudsley NHS Foundation Trust (GB), University of Oxford (GB)
South London and Maudsley NHS Foundation Trust, Maudsley Charity, National Institute for Health and Care Research, Medical Research Council
Good health and well-being
Openalex Percentile: Top 16%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.